Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Siedlce – page 8

140 clinical trials in Siedlce, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Siedlce at a glance
140
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

140 trials in Siedlce

Open in trial search

Weight control

Not recruiting

Study on Petrelintide for Weight Loss in Overweight or Obese Patients with Related Health Issues

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Petrelintide
  • Sponsor:Zealand Pharma A/S

Psoriatic arthropathy

Not recruiting

Study of sonelokimab injection in adults with active psoriatic arthritis who have not received biological DMARDs treatment before

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Sonelokimab
  • Sponsor:MoonLake Immunotherapeutics AG

Psoriasis

Not recruiting

Study on Long-term Safety and Effectiveness of Zasocitinib for Patients with Moderate-to-Severe Plaque Psoriasis

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Zasocitinib
  • Sponsor:Takeda Development Center Americas Inc.

Acne

Not recruiting

Title: Long-term safety study of N-Acetyl-GED-0507-34-LEVO gel 5% applied to the skin for patients with acne vulgaris

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years
  • Substances:Busegampar
  • Sponsor:PPM Services S.A.

Study on the Effects of Astegolimab and Drug Combination for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Genentech Inc.

Psoriasis

Not recruiting

Study on Long-Term Safety and Efficacy of Deucravacitinib for Patients with Moderate-to-Severe Plaque Psoriasis

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Dyslipidaemia

Not recruiting

Study of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Evolocumab
  • Sponsor:Amgen Inc.

Rheumatoid arthritis

Not recruiting

Study on the Effectiveness and Safety of Abatacept Biosimilar (DRL_AB) and Methotrexate for Patients with Moderate to Severe Rheumatoid Arthritis

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Abatacept
  • Sponsor:Dr Reddy's Laboratories Limited

Arteriosclerosis

Not recruiting

Study on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Obicetrapib
  • Sponsor:NewAmsterdam Pharma B.V.

Back pain

Not recruiting

Study on the Effects of VER-01, Ibuprofen, and Paracetamol for Patients with Chronic Non-Specific Low Back Pain

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Dronabinol
  • Sponsor:Vertanical GmbH

Endometriosis

Not recruiting

Study on the Effectiveness and Safety of OG-6219 and Naproxen Sodium for Women Aged 18-49 with Moderate to Severe Endometriosis Pain

Registered drug
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:FOR-6219
  • Sponsor:Organon LLC

Atrial fibrillation

Not recruiting

Study on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Andexanet Alfa
  • Sponsor:Janssen Cilag International

Other cities in Poland

The busiest research cities in the country

All 236 cities in Poland

Clinical research in Siedlce

What the registry says about research in the country

01 Oncology Studies

Extensive research focusing on various cancer types including non-small cell lung cancer, head and neck cancers, and advanced melanoma. Multiple trials evaluating novel immunotherapy combinations and targeted treatments.

  • Lung Cancer Therapies
  • Ovarian Cancer Treatments
  • Immunotherapy Combinations

Studies particularly emphasize innovative approaches for metastatic conditions and treatment-resistant cancers.

02 Metabolic Disorders

Comprehensive research into weight management and metabolic conditions, including trials for obesity and type 2 diabetes. Studies evaluate new therapeutic approaches combined with lifestyle modifications.

  • Weight Management Solutions
  • Diabetes Treatments
  • Metabolic Health Interventions

Focus on developing treatments that work alongside dietary and physical activity changes.

03 Autoimmune Conditions

Innovative trials addressing various autoimmune disorders, including rheumatoid arthritis, psoriatic arthritis, and Sjögren's disease. Research focuses on new biological treatments and disease-modifying therapies.

  • Arthritis Treatments
  • Psoriasis Therapies
  • Autoimmune Disease Management

Emphasis on developing targeted therapies for better disease control and symptom management.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.